LEGN Legend Biotech Corporation
$21.56▲ +5.74%
Healthcare
Other
After hours
$21.56▲ +0.00%
Oct 27, 4:18 PM ET
Volume 2.12M
Avg Volume (10D) 1.97M
Key Metrics & Fundamentals
Market Cap
$4.19B
P/E Ratio
–
Div Yield
0.00%
52W Range
16.24 - 37.50
% vs 50 MA
10.34%
% vs 200 MA
-2.66%
RSI-14
65.1
MACD Histogram
+0.3100
Beta (1Y vs SPY)
0.49
Free Cash Flow
-$28.40M
Gross Rev
$387.50M
Gross Profit
$250.10M
EBITDA
$75.50M
COGS
$137.40M
Operating Exp
$192.40M
Operating Income
$57.70M
EBIT
$57.70M
Pretax Income
$55.50M
Net Income
$33.20M
EPS (Diluted)
0.18
Price & Volume History
Loading chart…
Recent News
Legend Biotech Corporation Sponsored ADR (LEGN) Crossed Above the 50-Day Moving Average: What That Means for Investors
Zacks · Oct 27, 2026 8:30 AM ET
Legend Biotech to Host Investor Conference Call on Third Quarter 2026 Results
GlobeNewswire · Oct 27, 2026 8:00 AM ET
Morgan Stanley turns bearish on Vonovia, LEG as Berlin housing risks mount
Investing.com · Oct 20, 2026 6:28 AM ET
Legend Biotech Receives FDA Clearance for In Vivo CAR-T Therapy Trial
MT Newswires · Oct 15, 2026 8:57 AM ET
Legend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T Therapy
GlobeNewswire · Oct 15, 2026 8:00 AM ET
RBC Trims Price Target on Legend Biotech to $56 From $58, Keeps Outperform Rating
MT Newswires · Oct 8, 2026 7:42 AM ET
Legend Biotech (LEGN) Tests Its Valuation After Fresh CARVYKTI Five Year Data
Simply Wall St. · Oct 4, 2026 12:06 PM ET
Sector Update: Healthcare Stocks Steady Late Afternoon
MT Newswires · Oct 2, 2026 3:49 PM ET
Sector Update: Healthcare
MT Newswires · Oct 2, 2026 3:32 PM ET
Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says
MT Newswires · Oct 2, 2026 1:05 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See LEGN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.